We are driven by the passion to nurture and preserve the precious moments of everyday life for all people, regardless of their health condition. From treatment to disease prevention, we will continue to develop innovative new drugs that contribute to better health and bring smiles to the faces of people everywhere.
Latest News
-
September 24, 2024
News Releases
Taiho Pharmaceutical and Haihe Biopharma Announce the Launch of MET Inhibitor HAIYITAN ® Tablets 50mg in Japan（PDF：187.6 KB）
-
July 09, 2024
News Releases
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia（PDF：597.7 KB）
-
July 01, 2024
News Releases
Taiho Pharmaceutical Establishes New Company, Arirge Co., Ltd., to Address Social Issues Related to Cancer
-
May 30, 2024
News Releases
Otsuka Pharmaceutical and Taiho Pharmaceutical Commence Material Recycling of Waste PTP Used in Pharmaceutical Packaging（PDF：344.2 KB）
-
April 01, 2024
News Releases
Corporate Venture Capital Firm Taiho Ventures Selected for AMED's Strengthening Program for Pharmaceutical Startup Ecosystem （PDF：239.7 KB）
-
October 31, 2024
Information
Otsuka Holdings announces 3Q FY2024 financial results
-
June 07, 2024
Information
Otsuka Holdings announces Fourth Medium-Term Management Plan(2024-2028)
-
January 09, 2024
Information
Donations to Support Relief Efforts Following the Noto Peninsula Earthquake
-
February 22, 2023
Information
Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria
-
March 17, 2022
Information
■Otsuka Holdings Donations for Humanitarian Support to Ukrainian People
-
July 12, 2018
Information
Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）
MOVIE
TAIHO PHARMA STORY
Introducing Taiho Pharmaceutical’s history and its unique approaches in R&D.
This video is not intended to constitute promotion or advertisement of any products.